Lawrence J Heinz

Title: The Innovations of Lawrence J Heinz

Introduction

Lawrence J Heinz is a notable inventor based in Pittsboro, IN (US). He has made significant contributions to the field of neuroscience through his innovative work on excitatory amino acid receptors. With a total of 4 patents, Heinz has focused on developing compounds that can potentially treat various neurological disorders.

Latest Patents

One of Heinz's latest patents is related to NMDA receptor selective antagonists. This invention discloses novel piperidine tetrazole compounds that are selective antagonists of EAA receptors, particularly the NMDA receptors. The invention also provides formulations of the preferred compounds and methods for using these compounds to treat disorders associated with neuronal excitotoxicity. Another significant patent is for excitatory amino acid receptor antagonists. This invention presents novel compounds that affect excitatory amino acid receptors and are useful in treating neurological disorders. Additionally, it provides synthetic methods for preparing these novel compounds.

Career Highlights

Heinz is currently associated with Eli Lilly and Company, where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues for neurological conditions.

Collaborations

Heinz has collaborated with notable colleagues such as William H Lunn and Darryle D Schoepp, contributing to a rich environment of innovation and discovery.

Conclusion

Lawrence J Heinz's contributions to the field of neuroscience through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for neurological disorders.